Mathieu Xavier

Arrayon Biotechnology SA provides proprietary surface biofunctionalization technology to life science and medical markets. It offers patented linker polymer family, OptoDex, and proprietary surface functionalization technologies as it covers a large scope of applications from robust bioanalytics for in vitro diagnostics to biofunctionalization of surfaces of implants and medical devices. The company was founded on July 5, 2004 and is headquartered in Neuchatel, Switzerland.

Arrayon Biotechnology SA provides proprietary surface biofunctionalization technology to life science and medical markets. It offers patented linker polymer family, OptoDex, and proprietary surface functionalization technologies as it covers a large scope of applications from robust bioanalytics for in vitro diagnostics to biofunctionalization of surfaces of implants and medical devices. The company was founded on July 5, 2004 and is headquartered in Neuchatel, Switzerland.

Arrayon Biotechnology SA provides proprietary surface biofunctionalization technology to life science and medical markets. It offers patented linker polymer family, OptoDex, and proprietary surface functionalization technologies as it covers a large scope of applications from robust bioanalytics for in vitro diagnostics to biofunctionalization of surfaces of implants and medical devices. The company was founded on July 5, 2004 and is headquartered in Neuchatel, Switzerland.

Arrayon Biotechnology SA provides proprietary surface biofunctionalization technology to life science and medical markets. It offers patented linker polymer family, OptoDex, and proprietary surface functionalization technologies as it covers a large scope of applications from robust bioanalytics for in vitro diagnostics to biofunctionalization of surfaces of implants and medical devices. The company was founded on July 5, 2004 and is headquartered in Neuchatel, Switzerland.